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Abstract
A new conditionally immortal satellite cell-derived cell-line, H2K 2B4, was generated from the H2Kb-tsA58 immortomouse.
Under permissive conditions H2K 2B4 cells terminally differentiate in vitro to form uniform myotubes with a myogenic
protein profile comparable with freshly isolated satellite cells. Following engraftment into immunodeficient dystrophin-
deficient mice, H2K 2B4 cells regenerated host muscle with donor derived myofibres that persisted for at least 24 weeks,
without forming tumours. These cells were readily transfectable using both retrovirus and the non-viral transfection
methods and importantly upon transplantation, were able to reconstitute the satellite cell niche with functional donor
derived satellite cells. Finally using the Class II DNA transposon, Sleeping Beauty, we successfully integrated a reporter
plasmid into the genome of H2K 2B4 cells without hindering the myogenic differentiation. Overall, these data suggest that
H2K 2B4 cells represent a readily transfectable stable cell-line in which to investigate future stem cell based therapies for
muscle disease.
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Introduction
Primary myoblasts are routinely used as a cell model for muscle
research. However, their limited proliferation capacity in vitro
hinders their ability to be used in repeated experiments and
consequently numerous isolations of primary cells are required.
Whilst whole muscle digestion approaches are feasible, the time
consuming nature of these methods makes them less than ideal.
More importantly, myogenic heterogeneity within every extraction
may give rise to conflicting results between experiments. An
alternative approach is the use of established muscle cell-lines
which have extensive mitotic capacity whilst retaining their ability
to terminally differentiate in vitro and in vivo. The C2 sub-clone,
C2C12, is widely used, however, as the cell-line form tumours
when transplanted into muscle the cell model is limited to in vitro
based experiments [1,2,3]. In addition, studies conducting 2- and 3
dimensional cell culture experiments have shown differences in
myotube maturation as well as myogenic and adhesion protein
expression in C2C12 cells compared to primary myoblasts,
highlighting the importance of using a suitable cell-line when
investigating myogenic differentiation in vitro. [4,5,6,7]. In 1994,
Morgan et al. generated conditionally immortal myogenic cell-lines
from the H-2Kb-tsA58 immortomouse [8,9]. This transgenic
mouse harbours a temperature sensitive immortalising T-antigen
gene (tsA58) under the control of a gamma interferon inducible
MHC Class I promoter. Depending on culture conditions, the cells
either exhibit continuous mitosis or alternatively terminally
differentiate into myotubes. The conditionally immortal nature
of the myogenic cells have made them a valuable tool for
fundamental myogenic research as well as a suitable cell model for
screening drug compounds as potential treatment for Duchenne
muscular dystrophy [2,10,11,12,13]. Since 1994, conditionally
immortal myoblasts have been routinely used as cell models for
muscle research; however extensive in vitro and in vivo character-
isation on individual cell-lines has yet to be conducted. In addition,
as previous conditionally immortal cell-lines have been generated
from proliferating myogenic cells and not individual satellite cells,
it is possible that the commonly used cell models do not exhibit all
of the muscle stem cell qualities [8]. Whilst several studies have
used conditionally immortal satellite cell derived cell-lines to
address particular hypothesis, the clones were not extensively
characterised in vitro prior to their used in vivo [11,12].
Herein we described a new conditionally immortal satellite cell
derived cell-line, H2K 2B4, which was generated from the H-2Kb-
tsA58 immortomouse. The H2K 2B4 clone was extensively
characterised in vitro and in vivo and was shown to exhibit muscle
stem cell characteristics in both environments. The myogenic
clone was readily transfectable using retrovirus and the non-viral
transfection method, Nucleofection, which utilises electrical pulses
to introduce exogenous genes. Furthermore, using the Class II
transposon, Sleeping Beauty, we stably integrated a reporter plasmid
into the genome of the H2K 2B4 cells. Through analysing
integration sites, the Sleeping Beauty transposon exhibited a random
integration profile and did not hinder the proliferative or
myogenic potential of the H2K 2B4 clone, thus making it a safer
alternative to the use of integrating viruses in the generation of
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genetically modified cell-lines. Overall, H2K 2B4 cell-line has
proven to be a reliable ‘‘stem cell model’’ that is ideal for myogenic
research.
Materials and Methods
Isolating and culturing satellite cells from myofibres
Single myofibres were prepared from extensor digitorum longus
(EDL) muscles of a 3 week old male H-2Kb-tsA58 immortomouse
as previously described [14]. Single satellite cells were cultured in
Matrigel coated 6-well plates (0.1 mg/mL) growth medium
[DMEM, 20% (v/v) heat inactivated-foetal bovine serum, 2%
(v/v) chicken embryo extract (CEE, Sera laboratories internation-
al), 4 mM L-glutamine and 1% (v/v) penicillin/streptomycin].
Matrigel (B.D. Bioscience) was used to encourage cell adhesion.
Briefly, wells were coated in 0.1 mg/mL Matrigel (diluted in
DMEM), incubated for 30 minutes at 37uC before removing any
excess Matrigel. To initiate expression of the thermolabile T-
antigen protein, growth media was supplemented with 20 U/mL
of c-IFN (Chemicon) and the cells cultured at 33uC/10% CO2.
Evaluation of terminal differentiation of H2K 2B4 cells in
vitro
Myoblasts were cultured in differentiation medium [DMEM,
5% (v/v) Horse Serum (PAA Laboratories), 4 mM L-glutamine
and 1% penicillin/streptomycin] at a seeding density of 56104
myoblasts per well in a volume of 250 ml (LABTEK eight-well
chamber slides, Nunc). Prior to seeding, wells were coated in
0.1 mg/mL Matrigel, as described above. Myoblasts were
incubated for three days at 37uC, 5% CO2 without c-IFN. The
medium was not changed as this tended to disrupt myotube
formation. H2K 2B4 myoblasts and myotubes were fixed with 4%
paraformaldehyde (PFA, Sigma), permeabilised with 0.5% Triton
(Sigma) and blocked with 10% goat serum (DakoCytomation).
Myoblasts and myotubes were incubated with primary antibodies
directed to the following proteins, Pax7 (developmental studies
hybridoma bank, DSHB), MyoD (5.8A, DAKO), myogenin (F5D,
DSHB), desmin (D33, DAKO) fast and slow myosin (MF20,
DSHB) and T-antigen (EMDA Biosciences). Primary antibodies
were detected with an appropriate fluorescent secondary antibody.
Nuclei were counterstained with DAPI (100 ng/mL, Invitrogen).
In vivo characterisation of the H2K 2B4 cell-line
Ethical statement. All animal experiments were carried out
under license from the Home Office (UK) in accordance with The
Animals (Scientific Procedures) Act 1986 and with approval from
Imperial College ethical review process.
Contribution to skeletal muscle regeneration in mdx nu/
nu mice. Prior to irradiation, mice were anaesthetised with
Hypnorm (fentanyl/fluanisone, Janssen animal health, UK) and
Hypnovel (midazolam, Roche) at a ratio of 1:1:2 in injection grade
water. Hindlimbs of mdx nu/nu mice were irradiated with 18 Gy
at a dose rate of 0.7 Gy/minute [17]. Three days post irradiation,
2 male and 5 female 3 week old mdx nu/nu mice were
anaesthetised with isoflurane (Abbott Laboratories) and injected
with 56105 H2K 2B4 cells (total volume of 4 mL) into each
irradiated tibialis anterior (TA) muscle. Post-mortem, the
engrafted TA muscles were frozen in isopentane pre-chilled in
liquid nitrogen 3 and 24 weeks post transplantation. Dystrophin
protein expression was detected on 7 mm transverse muscle
sections using the polyclonal antibody P7 at a 1/1000 dilution
[15].
Contribution of functional donor cells to the satellite cell
compartment. To identify donor derived satellite cells in vivo,
the H2K 2B4 cell-line was infected with 50 cfu/mL of supernatant
from the pMFG nls LacZ retrovirus, and 8 mg/mL of polybrene
[12,16]. Nuclear localising beta-galactosidase activity was assessed
with X-gal solution as previously described [17]. Transduced H2K
2B4 cells were sub-cloned to generate H2K SC6, a conditionally
immortal cell-line with homogenous beta-galactosidase expression.
Half a million H2K SC6 cells were engrafted into irradiated TA
muscles of two female 3 week old mdx nu/nu mice (mice were
anaesthetised and irradiated as described above). Three weeks post
engraftment, TA muscles were removed and myofibres were
isolated as previously described (Collins and Zammit, 2009).
Isolated myofibres were fixed with 4% PFA, blocked with 10%
goat and 10% (v/v) swine serum (DakoCytomation) and
immunostained with antibodies towards the beta-galactosidase
(Molecular probes) and Pax7 proteins, myonuclei were
counterstained with DAPI.
To verify donor derived satellite cells were functional, 56105
H2K SC6 cells were engrafted into irradiated right and left TA
muscles of six 23–25 day old male mdx nu/nu mice (mice were
anaesthetised and irradiated as above). Twenty-one days later
mice were reanaesthetised and right TA muscles were injected
with 10 mL of Notechis scutatus scutatus notexin (10 mg/mL in PBS,
Latoxan, France). Left TA muscles were not treated with notexin.
Seven days later both TA muscles were removed and immuno-
stained with antibodies targeting neonatal myosin (BF34, DSHB)
and dystrophin (P7) proteins. To confirm myofibres were from
donor origin, serial sections were stained with X-gal solution to
detect beta-galactosidase activity and hematoxylin and eosin
(H&E) to assess muscle morphology. Within notexin treated
muscle, myofibres co-expressing neonatal myosin and dystrophin
within areas expressing beta-galactosidase were counted. As we
used a nuclear localising LacZ gene, we did not count beta-
galactosidase myofibres to estimate regeneration efficiency as this
would have underestimated the number of donor derived
myofibres, as previously described [18,19].
Genetically modifying H2K 2B4 cells using non viral
transfection methods
Optimising non-viral transfection methods. When using
Lipofectamine 2000, H2K 2B4 cells were seeded at 16105 cells/
well into six-well plates. The following day the H2K 2B4
myoblasts were transfected with Lipofectamine 2000 according
to the manufacturer’s instructions. For Nucleofection, 56105 H2K
2B4 cells were resuspended in 100 mL of Amaxa solution V prior
to adding the appropriate amount of plasmid DNA (amount
dependant on experiment). Cell suspensions were nucleofected
using programme B-032 on the Nucleofector II machine (Lonza).
Transient transfection efficiencies were analysed using a BD FACS
Calibur flow cytometry 48 hours post transfection. To ensure
analysis was conducted on viable cells propidium iodide (1/500
dilution, 1 mg/mL, Invitrogen) was added to samples prior to
analysis. For each sample, 10,000 viable cells were counted using
the Cell-Quest Programme.
Optimising stable integration of the Sleeping Beauty
transposon. The reporter plasmid, pMONO-neo-eGFP
(originally pMONO-neo-LGFP from Invivogen, LGFP was
replaced with eGFP gene), was inserted in between the terminal
repeats of the SB transposon plasmid, pT2/BH [20], creating a
new transposon called pT2/MONO-neo-eGFP. For the in vitro
transposition assay different amounts of a plasmid expressing the
hyperactive transposase, SB100 [21], were used to determine the
optimal ratio of the SB transposon to SB transposase. Using
Nucleofection, 56105 H2K 2B4 cells were co-transfected with
500 ng of pT2/MONO-neo-eGFP and varying amounts of SB100
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transposase plasmid (0, 10, 50, 100, 250, 500 & 1000 ng). Forty-
eight hours post transfection, growth medium was replaced with
fresh growth media supplemented with 800 mg/mL of G418.
Growth media supplemented with 800 mg/mL of G418 was
changed every 2–3 days. G418 resistant clones were counted after
14 days of G418 selection.
Analysis of Sleeping Beauty transposon integration
sites. Genomic DNA (gDNA) was extracted from a mixed
population of H2K 2B4 G418 resistant colonies, digested with the
SspI enzyme and cleaned within phenol:chloroform:isoamyl alcohol
prior to ligation. To encourage self ligation, gDNA was ligated using
3 U of ligase (Roche) in a total volume of 500 ml at 22uC overnight.
Ligated gDNA was cleaned with phenol:chloroform:isoamyl alcohol,
precipitated in ethanol and electroporated into 50 ml of ElectroMAX
DH10B T1 phage competent bacteria (Invitrogen). Transformed
bacteria were grown overnight at 30uC on LB agar plates containing
kanamycin (50 mg/mL, Sigma). Kanamycin resistant colonies were
Figure 1. Myogenic protein expression of H2K 2B4 cells during
terminal differentiation. H2K 2B4 cells were grown in non-
permissive conditions (37uC and no c-IFN)) over a four day period to
assess myogenic protein expression during terminal differentiation in
vitro. Cells were fixed daily with 4% PFA, at similar time points.
Timelines show the variation in protein expression during the 96 hour
time period. Error bars were generated from standard error of the mean
(SEM). N value of 5 for each protein and time point.
doi:10.1371/journal.pone.0024826.g001
Figure 2. Comparison of myogenic protein expression in H2K
2B4 myoblasts and myotubes. Images comparing protein expres-
sion in proliferating H2K 2B4 myoblasts and terminally differentiated
myotubes. MF20 antibody targets fast and slow myosin. T-antigen and
myogenic proteins are shown in green. Nuclei were counterstained with
DAPI (blue). Scale bars: 50 microns.
doi:10.1371/journal.pone.0024826.g002
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counter selected on LB agar plates supplemented with kanamycin
and ampicillin (50 mg/mL, Sigma). Plasmid DNAwas extracted from
Kanresistant and Ampsensitive colonies and integrations sites were
analysed using primers that hybridise to the left and right terminal
repeats of the transposon (Left ITR: 59GACTTGTGTCATG-
CACAAAGTAG and Right ITR: 59CCACTGGGAATG-
TGATGAAAG [39]). Sequencing reactions were analysed using a
nucleotide basic local alignment search tool (nBLAST) against the
NCBI mouse genome database. Of the 90 sequencing reactions
analysed, 58% were transposase mediated unique integration sites
which were mapped, the remaining were discarded (14% were non-
transposase mediated integrations, 14% repeated integration sites of
transposase mediated integration and 10% bad sequencing, thus
preventing mapping of integration sites).
Figure 3. H2K 2B4 cells regenerate muscle in vivo. Half a million H2K 2B4 cells were engrafted into irradiated TA muscles of seven mdx nu/nu
mice. A) Images showing dystrophin positive myofibres (red) derived from donor H2K 2B4 cells three weeks post transplantation and B) twenty-four
weeks post transplantation. Nuclei were counterstained with DAPI (blue). Scale bars: 50 microns. C) No significant difference in the number of
dystrophin positive myofibres was observed between 3 weeks and twenty-four weeks post transplantation. P.0.05, Mann Whitney test. Error bars
were generated from SEM. N value of 8 and 6 mice for 3 weeks and twenty-four weeks post transplantation, respectively.
doi:10.1371/journal.pone.0024826.g003
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Imaging
Immunofluorescent images were captured using a Leica DMR
microscope (Leica Microsystems, Germany) interfaced with
MetaMorph (Molecular Devices, USA). Images were taken at set
exposures when comparing groups. For cell counts, five random
fields containing approximately 100 myonuclei were chosen.
Statistical analysis
All data are presented as means 6SEM. Statistical analysis was
performed either by a Mann-Whitney test or a one way ANOVA
followed by a post hoc Tukey’s multiple comparison test. Statistical
significance was defined as a value of p,0.05.
Results
Generation of satellite cell derived cell-lines
To assess heterogeneity, doubling times and myogenicity was
evaluated for four satellite cell derived cell-lines. All clones had
similar doubling times; however a variation in the formation of
multinucleated myotubes and the expression of the myogenic
proteins Pax7, MyoD, myogenin and slow myosin was observed
between the clones (Figure S1a). The H2K 2B4 cell-line was the
most myogenic clone as it formed more multinucleated myotubes
compared to the other cell-lines and was therefore chosen for
further characterisation (Figure S1b).
Differentiation of the H2K 2B4 cell-line in vitro
An in vitro differentiation assay was conducted to evaluate
myogenic protein expression during terminal differentiation. Over
a four day differentiation assay the expression of Pax7, MyoD,
myogenin, desmin, fast/slow myosins and the immortalising
protein, T-antigen were assessed daily. Myotube formation began
within twenty-four hours after switching to differentiation
conditions (37uC & no c-IFN) with the myotube size increasing
throughout the assay. At day 0 (cells were fixed once they had
adhered to the plate, approximately 3 hours post seeding) over
80% of myoblasts expressed Pax7, a protein associated with
quiescent and activated satellite cells, as well as MyoD, a protein
required to initiate terminal differentiation (Figure 1). Within the
first twenty-four hours myogenin expression was markedly up-
regulated and the number of nuclei expressing myogenin increased
over the 96 hours, indicating that the majority of myoblasts had
committed to terminal differentiation. In contrast to myogenin,
cells expressing the Pax7 protein steadily decreased to 5% by
96 hours. Throughout the differentiation assay, myotube matura-
tion coincided with the down-regulation of the thermolabile T-
antigen, confirming the immortalising protein did not inhibit the
natural myogenic characteristics of the cell-line (Figures 1 and 2).
The H2K 2B4 cell-line readily formed multinucleated myotubes
even after extensive cell culturing (tested in cells up to 24
continuous passages). Overall, the expression profiles of the
myogenic proteins were comparable to previous literature on
freshly-isolated satellite cells [22], showing that the H2K 2B4 clone
was a good satellite cell model in vitro.
Regeneration of skeletal muscle by the H2K 2B4 clone
To determine if the H2K 2B4 cell-line was capable of
regenerating skeletal muscle, the cells were engrafted into mdx
nu/nu mice, a dystrophin deficient mouse model [23,24]. 56105
H2K 2B4 cells generated a mean of 279 dystrophin positive
myofibres (n = 8, SEM=137.4) three weeks post engraftment.
There was no significant difference in the number of dystrophin
positive myofibres 24 weeks post engraftment (mean= 173, n= 6,
SEM=99.15) (Figure 3). More importantly, engrafted muscles
were of normal size and morphology indicating the H2K 2B4 cell-
line did not form tumours in vivo (data not shown).
H2K 2B4 cells form functional satellite cells in vivo
In addition to regenerating dystrophic muscle, we investigated if
H2K 2B4 cells were capable of contributing functional satellite
cells to the satellite cell population in vivo. In order to distinguish
between donor and host satellite cells, we generated a beta-
galactosidase expressing satellite cell derived cell-line, H2K SC6,
which had been sub-cloned from genetically modified H2K 2B4
cells. Through in vitro analysis we confirmed the H2K SC6 clone
maintained the myogenic properties of the H2K 2B4 clone. 56105
H2K SC6 cells were injected into irradiated TA muscles of two
female mdx nu/nu mice. Myofibres were isolated three weeks post
engraftment and stained with antibodies to the satellite cell
marker, Pax7 and beta-galactosidase, to identify nuclei of donor
origin. We analysed 41 myofibres from 4 engrafted TA muscles
and we identified 71 satellite cells, of which 37 (52%) were of
donor origin (b-gal and Pax7 positive). Figure 4A shows a
Figure 4. Isolated myofibres from engrafted TA muscles
showing H2K SC6 derived satellite cells. H2K SC6 cells were
engrafted into irradiated TA muscles of two mdx nu/nu mice. Three
weeks post transplantation myofibres were isolated and stained for the
quiescent maker, Pax7. Donor derived satellite cells were confirmed by
the expression of the detection marker beta-galactosidase. A) A H2K
SC6 derived satellite cell expressing Pax7 and beta-galactosidase. B)
Host ‘‘radiation resistant’’ satellite cell expressing the Pax7, but not
beta-galactosidase. Magnification640, Scale bars: 50 microns.
doi:10.1371/journal.pone.0024826.g004
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Figure 5. Donor derived H2K SC6 satellite cells give rise to functional satellite cells. Tibialis anterior muscles of six male mdx nu/nu mice
were irradiated and injected with 56105 H2K SC6 cells. To determine if H2K SC6 derived satellite cells were functional the right engrafted TA muscle
were challenged with notexin three weeks post transplantation. The left engrafted TA muscles were not treated with notexin. Seven days later both
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representative image of our findings with a nucleus positive for
both the Pax7 and beta-galactosidase protein showing that the
satellite cell was of donor origin. Pax7 positive/beta-galactosidase
negative nuclei was also detected (Figure 4B), which were likely to
be to be ‘‘radiation resistant’’ satellite cells [25]. To ensure the
donor derived satellite cells were functional an experimentally-
induced muscle regeneration study was conducted [17,18,26,27].
56105 H2K SC6 cells were injected into each irradiated TA
muscle of six male mdx nu/nu mice. Three weeks post
transplantation, notexin was injected into the right TA muscle.
The left TA muscle was not treated with notexin. Seven days later,
TA muscles were removed post-mortem and the expression of
dystrophin and neonatal myosin was assessed. Both notexin and
non-notexin treated muscles contained myofibres co-expressing
dystrophin and neonatal myosin. However, the numbers of
myofibres co-expressing the two proteins was significantly greater
in notexin treated muscles, indicating recent regeneration (n= 6,
p = 0.0129) (Figure 5a, b, c). H&E (for muscle morphology) and X-
gal (for beta-galactosidase activity) stains confirmed newly-
regenerated myofibres were of donor origin, evidence that the
H2K SC6 cells were capable of forming functional satellite cells in
vivo (Figure 5d,e).
Genetically modifying the H2K 2B4 cell-line
We have shown the H2K 2B4 cell-line can be readily
transduced with the pMFG nls LacZ retrovirus, an observation
consistent with previous conditionally immortal cell-lines
[2,11,12]. We next investigated if the H2K 2B4 cell-line could
be efficiently genetically modified using non-viral transfection
methods as limited work on such a system has been conducted to
date. Two non-viral transfection methods, Lipofectamine 2000
and Nucleofection, were assessed. Using Lipofectamine, 30% of
the H2K 2B4 cells transiently expressed the eGFP protein,
whereas, Nucleofection yielded greater transient cell transfection
efficiencies of 50–70%. Although not quantified, Nucleofection
resulted in a lower cell toxicity compared to Lipofectamine 2000.
When using Nucleofection, genetically modified H2K 2B4 cells
were able to differentiate into multinucleated myotubes in vitro
(Figure S2). In addition, the H2K 2B4 clone was readily
transfectable even after 27 continuous passages (approximately
80 doublings). Subsequently, we explored the possibility of stably
integrating a reporter plasmid into the genome of the H2K 2B4
cells using the Sleeping Beauty transfer system [28]. Using
Nucleofection, H2K 2B4 cells were co-transfected with the SB
transposon, pT2/MONO-neo-eGFP, and varying amounts of the
hyperactive SB100 transposase plasmid (0, 10, 50, 100, 250, 500 &
1000 ng). Transfected cells were selected with G418 for two weeks
and G418 resistant colonies were counted. H2K 2B4 cells
transfected with the minimum amount of SB100 plasmid
(50 ng), had a significant increase in the number of G418 resistant
colonies compared to the negative control (n = 4, p,0.05). A six
fold increase in G418 resistant colonies was observed when using
1000 ng of the SB100 transposase plasmid (Figure 6). To confirm
the increase in G418 resistant colonies was due to transposase
mediated integration rather than non-transposase mediated
integration (insertion into the genome without the use of the
SB100 transposase), we analysed the integration sites using a
plasmid recovery strategy [29]. The plasmid recovery technique
distinguishes between non-transposase mediated integration and
transposase mediated integration on the basis of antibiotic
resistance in bacterial colonies. Colonies which are Kanresistant/
Ampresistant indicate non-transposase mediated integration, where-
as Kanresistant/Ampsensitive colonies indicate transposase mediated
transposition (Figure S3). Like other Tc1 transposons, the SB
system has a signature integration profile of targeting TA
dinucleotides [30]. Once integrated, the transposon generates
TA dinucleotides flanking either side of the terminal repeats, thus
allowing the confirmation of transposition events at a molecular
level. From the 53 unique integration sites analysed, the
integration profile of the SB system was random, as it did not
target a particular chromosome or gene region (Figure 7), an
observation that has been previously reported in other cell types
[30,31,32,33]. Of the 53 unique integration sites, 33% were found
in active genes, of which all were in introns. Furthermore, the
Figure 6. Sleeping Beauty transposition assay in the H2K 2B4
cell-line. 500 ng of the Sleeping Beauty (SB) pT2/MONO-neo-eGFP
plasmid and varying amounts of the SB100 transposase plasmid (0, 10,
50, 100, 250, 500, 1000 ng) was co-transfected into the H2K 2B4 cell-
line. H2K 2B4 G148 resistant colonies were counted after 14 days of
G418 selection. A significant increase in G418 resistant colonies was
observed with cells co-transfected with 50,100, 250, 500 and 1000 ng of
the SB100 transposase plasmid compared to the cells transfected with
the transposon only, suggesting transposase mediated integration had
occurred. *** p,0.001. One way ANOVA and Tukey test, N value of four.
Error bars generated by SEM.
doi:10.1371/journal.pone.0024826.g006
TA muscles were removed and H2K SC6 derived satellite cell function was assessed by the number of myofibres co-expressing Dystrophin (Dys) and
Neonatal Myosin (NM). A) Engrafted TA muscles treated with notexin had a significant increase in the number of myofibres co-expressing Dys+ (red)
and NM+ (green) positive compared to the non-notexin treated contralateral muscle TA muscle. Myonuclei were counterstained with DAPI (blue).
Mann Whitney test, p = 0.0129, N value of 6. Error bars were generated from SEM. B&C) Images showing an increased number of Dys+ (red) and NM+
(green) myofibres in an engrafted TA muscle treated with notexin, compared to a non-notexin treated engrafted muscle and control muscle (no H2K
SC6 cells or notexin). H&E and X-gal staining of serial sections confirmed regenerating myofibres were from donor origin (D&E). Asterisks showing the
same myofibre in serial sections. Scale bars: 50 microns.
doi:10.1371/journal.pone.0024826.g005
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stable integration of the SB transposon did not hinder the
differentiation ability of the H2K 2B4 cell-line in vitro (Figure 8).
Discussion
Myogenic cells from the H-2Kb-tsA58 immortomouse are an
ideal cell model system for muscle research, due to extensive
mitotic capability and good fusion rate in vitro and in vivo [8].
Whilst previous studies have used conditionally immortal myo-
genic cell-lines to address particular hypotheses [10,11,12,17],
extensive in vitro and in vivo characterisation on a particular
myogenic cell-line from the H-2Kb-tsA58 immortomouse has not
been conducted. Furthermore, as many previous conditionally
immortal cell-lines were derived from enzymatically-disaggregated
newborn mouse muscle, they may not be satellite cell derived and
could instead represent another stem cell present in skeletal muscle
Figure 7. Integration sites of the Sleeping Beauty transposon within the genome of H2K 2B4 cells. A) Molecular proof of SB transposon
integration in the H2K 2B4 cells. Sequencing results showing duplicated TA dinucleotides sites flanking left and right terminal repeat of the Sleeping
Beauty transposon. B) Schematic diagram showing integration profile of 53 unique SB transposon integration sites within the H2K 2B4 genome.
doi:10.1371/journal.pone.0024826.g007
A New Extensively Characterised Muscle Cell-Line
PLoS ONE | www.plosone.org 8 September 2011 | Volume 6 | Issue 9 | e24826
[34]. In light of this, we generated a satellite cell derived clone
from the H-2Kb-tsA58 immortomouse and assessed its potential to
represent a good ‘‘muscle stem model’’ in vitro and in vivo.
Each conditionally immortal cell-line was generated from a
single satellite cell that had migrated away from a myofibre. This
was deemed the best isolation method as it ensured the clones were
generated from a satellite cell, and prevented contamination from
other cell-types present within the muscle. Initial characterisation
showed that despite similar doubling times, the ability to form
multinucleated myotubes varied between the four cell-lines. It is
likely the difference in myogenicity is due to satellite cell
heterogeneity [19,26,35]. The H2K 2B4 cell-line was chosen for
further characterisation as it reliably formed multinucleated
myotubes in vitro and therefore was deemed the most myogenic
clone. Myogenic transcription factors such as Pax7, MyoD and
myogenin play an important role in the satellite cell cycle [22,36].
We therefore analysed their expression levels in the H2K 2B4 cells
during myogenic terminal differentiation in vitro. Using a robust
differentiation assay we confirmed that despite continuous
proliferation (approximately 22 doublings), when switched to
non-permissive conditions, the H2K 2B4 cell-line exhibited similar
myogenic protein expression as seen in freshly isolated satellite
cells [22,37]. The H2K 2B4 cell-line was also capable of forming
uniform myotubes after 24 continuous passages (approximately 68
doublings), confirming the cell’s myogenicity was not affected by
extensive cell culturing. The combination of continuous prolifer-
ation whilst retaining a similar terminally differentiating pattern as
satellite cells suggests the H2K 2B4 cell-line represents a good
‘‘stem cell model’’ for in vitro studies.
When transplanted into irradiated TA muscles of mdx nu/nu
mice the H2K 2B4 cells regenerated host muscles at similar
efficiencies to other conditionally immortal muscle cell-lines
[11,12]. More importantly, the clone was able to form stable
myofibres, without forming tumours as seen with C2C12 cells,
highlighting the advantage of using H-2Kb derived cell-lines [1,2].
In addition to regenerating dystrophic muscle, the H2K 2B4 clone
was capable of contributing functional satellite cells to the satellite
cell niche in vivo, an imperative quality which ensures long-term
persistence of donor derived cells in vivo. Interestingly, during in
vitro terminally differentiation we identified 5% of H2K 2B4 nuclei
expressing Pax7 96 hours after being switched to non-permissive
conditions. Therefore, it is possible this subset of Pax7 positive cells
is a ‘‘stem-cell’’ population which was responsible for the
regeneration and re-occupying the satellite cell niche upon muscle
transplantation. Thus, the myogenic protein expression of H2K
2B4 cells is not homogenous and like satellite cells, the H2K 2B4
cells may adopt divergent fates [19,22].
Overall, in conjunction with the in vitro characterisation, the in
vivo experiments confirmed the H2K 2B4 cell-line exhibited
satellite cell qualities making it an ideal cell model for muscle
research.
To further validate the H2K 2B4 cell-line as a robust muscle
stem cell model we investigated if the cell-line was readily
transfectable using viral and non viral techniques. Consistent with
previous conditionally immortal cell-lines, the H2K 2B4 cell-line
was readily transduced when using the pMFG nls LacZ retrovirus
[11,12]. Conditionally immortal myogenic cells are routinely
genetically modified with retroviruses as these hard-to-transfect
cells yield low transfection efficiencies when using non viral
transfection methods such as Lipofectamine 2000. However, here
we have shown the H2K 2B4 cell-line can be efficiently transfected
and maintain good cell viabilities when using a less toxic non viral
transfection method, Nucleofection. This transfection method
combines electrical pulses with specific cell-type solutions to
introduce exogenous DNA into the nucleus of target cells. We also
showed the cell-line was readily transfectable after extensive cell
culturing (tested in cells with up to 80 cell doublings), thus
confirming the clone is suitable for long-term experiments. In
addition to transient transfection efficiencies, we sought to evaluate
stable transgene expression using a non-viral system such as
Sleeping Beauty (SB), a class II DNA transposon [28]. Utilising its
inherent ability to integrate into host genomes, the SB system has
been used to introduce reporter and therapeutic genes into a
variety of target cells [38,39,40,41,42]. Here we showed the SB
system was capable of stably integrating a reporter plasmid into
the genome of the H2K 2B4 cells without hindering the myogenic
characteristics of the cell-line. In addition, the SB transposon
exhibited a random integration profile with 33% of the integrants
being identified in intronic sequences of active genes, an
observation consistent to previous studies in other cell-lines
[30,31,33]. Whilst the integration profile of the SB transposon is
deemed safer than retroviral vectors, further work is still required
to guarantee integration into pre-determined genome sites and
thus prevent any potential insertional mutagenesis. Overall, we
can confirm the H2K 2B4 clone is readily transfectable using both
viral or non-viral transfection methods and that most importantly;
genetic modification does not hinder the myogenicity of the line.
Our current findings extend the original work of Morgan and
colleagues [8]. In that paper, cells were obtained by enzymatic
disaggregation of mouse hindlimb muscles so it was not possible to
Figure 8. In vitro differentiation of H2K 2B4 cells genetically
modified with the Sleeping Beauty transposon. To determine if
genetically modified H2K 2B4 cells were still able to retain their
differentiation ability post genetic modification the cell-line was grown
in non permissive conditions (37uC and no c-IFN). Myotubes were
immunostained with antibodies towards myogenic proteins (MyoD,
myogenin and desmin) and for the transgenic marker, GFP. Scale bars:
50 microns.
doi:10.1371/journal.pone.0024826.g008
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determine either what muscle the cells were derived from, or if
they were indeed (as would be expected) satellite cell-derived. The
in vitro myogenicity of clones derived and expanded from these
muscles was verified, but not quantified and the myogenicity of
only one clone was determined on western blot, using an antibody
to myogenin. In this study, we prepared cells from isolated fibres of
mouse EDL muscles, so we know both the muscle of origin and
that the myogenic cells were indeed satellite cell-derived. In
addition, we used antibodies to Pax 7, MyoD, myogenin, desmin
and myosin to determine the timing and extent of activation,
commitment to differentiation, myogenic differentiation and self-
renewal of a satellite cell derived cell-line [22]. These data
provides a detailed baseline for future users of this clone and can
used to determine whether any interventions have had a
deleterious effect on the cell’s myogenic capacity. The H2K 2B4
cell-line therefore represents a robust reagent for research into
muscle cell biology, in contrast to other less well-characterised
immortomouse myogenic cell lines [43,44,45].
Some of the original H2KbtsA58 clones developed by Morgan
and colleagues, were serially-passaged from one host mouse to
another, to show that they had given rise to cells of donor origin
that retained their capability of contributing to muscle regener-
ation [8]. However, it was not determined whether the original
grafted cells had given rise to cells in the satellite cell position. In
contrast, we have demonstrated here that at least some of our
grafted H2KB4 myoblasts gave rise to satellite cells of donor
origin.
In summary, this study generated a conditionally immortal satellite
cell derived cell-line from theH-2Kb-tsA58 immortomouse. Extensive in
vitro and in vivo characterisation confirmed the H2K 2B4 clone exhibits
muscle stem cell characteristics. The stem cell model could be readily
transfected using viral and non-viral techniques. More importantly,
using the SB system, we have shown the H2K 2B4 cell-line can be
genetically modified without hindering the cell’s natural characteristics.
Overall the H2K 2B4 cell-line combines the myogenic characteristics
of satellite cells and the longevity and reliability of a cell-line, making
the clone an ideal cell model for muscle research.
Supporting Information
Figure S1 Comparison of myogenic protein expression
in terminal differentiated in H-2Kb clones. Satellite cell
derived clones were grown in non permissive conditions (37uC+no
c-IFN) for three days and myogenic protein expression was
assessed within the terminally differentiated myotubes. A)
Myogenic proteins (MyoD, Slow/Fast myosin and Myogenin)
were significantly lower in the H2K 3A4 cell-line compared to the
other clones. No significant difference in myogenic protein
expression levels was observed between the remaining cell lines.
MF20 antibody targets fast & slow myosin. * p,0.05, ** p,0.01,
*** p,0.001, One way ANOVA and Tukey test. Error bars
generated from SEM, N value of 4.B) Images showing terminally
differentiated conditionally immortal clones. Scale bar: 20 mi-
crons.
(TIF)
Figure S2 Terminal differentiation of genetically mod-
ified H2K 2B4 cells. Using Nuclefection, the H2K 2B4 cell-line
was transfected with 2.5 mg of the pMONO-neo-eGFP plasmid,
48 hours post transfection transient expression of eGFP protein
was detected using flow cytometry. B) Images showing genetically
modified H2K 2B4 myotubes formed from H2K 2B4 myoblasts
transiently expressing the eGFP gene. Scale bar: 50 microns.
(TIF)
Figure S3 Analysing Sleeping Beauty integration sites
within H2K 2B4 cells using the plasmid recovery
method. A) Schematic diagram of the Sleeping Beauty (SB)
transposon, pT2/MONO-neo-eGFP. The plasmid contains
SB100 transposase binding sites within the inverted terminal
repeats (IRDR, purple triangles). The IRDRs flank an eGFP gene,
neo gene and a ColE1 origin of replication (ori) region. The neo
gene confers resistance to G418 and kanamycin in mammalian
cells and E.coli, respectively. The plasmid backbone contains an
ampicillin resistance gene and another ColE1 ori region, to
distinguish between transposon mediated and random integration
when using the plasmid recovery method. B) A diagram to show
the two possible integration outcomes of the pT2/MONO-neo-
eGFP. Firstly by transposition, a transposase meditated integra-
tion, resulting in kanamycin resistance within E.coli. Secondly, by
random integration resulting in resistance to both kanamycin and
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